Search clinical trials for: Palbociclib + an aromatase inhibitor
Total 1354 results
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
PfizerCompletedMetastatic Breast CancerUnited States
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
PfizerCompletedBreast NeoplasmsQatar, United Arab Emirates, Saudi Arabia
-
PfizerCompleted
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Estrogen Receptor Positive TumorSweden
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
International Cancer Research Group, United Arab...King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut... and other collaboratorsRecruitingHormonal Receptors Positive, HER2 Negative, Advanced Breast CancerAlgeria, Jordan, Saudi Arabia
-
Canadian Cancer Trials GroupPfizerCompleted
-
Sudipto MukherjeeActive, not recruitingAcute Myeloid Leukemia | AMLUnited States
-
Institut für Klinische Krebsforschung IKF GmbH...Recruiting
-
Nordic Society of Gynaecological Oncology - Clinical...European Network of Gynaecological Oncological Trial Groups (ENGOT); Grupo... and other collaboratorsCompletedEndometrial CancerDenmark
-
NSABP Foundation IncRoyal Marsden NHS Foundation Trust; Pfizer; Institute of Cancer Research, United...CompletedBreast Cancer | Breast Tumors | Breast CarcinomaUnited Kingdom, United States, Canada
-
PfizerCompleted
-
Shengjing HospitalRecruiting
-
Borstkanker Onderzoek GroepActive, not recruitingBreast Neoplasm FemaleNetherlands
-
PfizerCompletedBreast NeoplasmsSpain, Korea, Republic of, United States, Australia, Italy, Russian Federation
-
PfizerCompleted
-
MedSIRPfizerCompletedBreast CancerSpain, Portugal
-
Latin American Cooperative Oncology GroupPfizerCompleted
-
PfizerCompleted
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Hormone Receptor Positive TumorSweden
-
PfizerCompleted
-
Tvardi Therapeutics, IncorporatedActive, not recruiting
-
MegalabsNot yet recruiting
-
PfizerActive, not recruiting
-
Guangdong Provincial People's HospitalNot yet recruitingNeoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
-
Memorial Sloan Kettering Cancer CenterPfizerCompletedSarcoma | LiposarcomaUnited States
-
Weill Medical College of Cornell UniversityRecruiting
-
University of Colorado, DenverPfizer; Criterium, Inc.; Cascadian Therapeutics Inc.CompletedBreast CancerUnited States
-
PfizerCompletedHealthy, Hepatic InsufficiencyUnited States
-
Massachusetts General HospitalGenentech, Inc.Active, not recruiting
-
Weill Medical College of Cornell UniversityWithdrawn
-
PfizerCompleted
-
PfizerCompleted
-
University of Kansas Medical CenterPfizerTerminatedHER2-positive Breast Cancer | Breast Cancer MetastaticUnited States
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
PfizerCompletedHealthyUnited States
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
PfizerCompleted
-
InventisBio Co., LtdCompleted
-
PfizerRecruiting
-
PfizerCompletedHealthyUnited States
-
University of NebraskaRecruitingClinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine TherapyBreast CancerUnited States
-
PfizerRecruitingBreast NeoplasmsAustria, Germany
-
Royal Marsden NHS Foundation TrustPfizer; Roche Pharma AG; Institute of Cancer Research, United KingdomUnknownBreast Cancer | Advanced Solid TumoursUnited Kingdom
-
PfizerNo longer available
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina